MktsMarkets

LENZ Therapeutics, Inc.
NASDAQ: LENZKey statistics
LENZ News
Stories mentioning LENZ from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,901 | 0.00 | ||||||
| Cost of Goods Sold | 1,076 | 0.00 | ||||||
| Gross Profit | 825.00 | 18,670 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 0.00 | 0.00 | 3,791 | 9,061 | 5,818 | 5,868 | 6,451 | 6,945 |
| Sales General & Admin | 44,960 | 39,633 | 27,596 | 12,796 | 11,113 | 9,357 | 6,494 | 7,407 |
| Total Operating Expenses | 31,387 | 21,857 | 16,931 | 15,225 | 12,945 | 14,352 | ||
| Operating Income (Loss) | (44,135) | (38,463) | (18,887) | (16,857) | (16,931) | (15,225) | (12,945) | (14,352) |
| Interest Income | 2,644 | 2,986 | 2,201 | 2,246 | 2,323 | 2,566 | 2,736 | 2,463 |
| Interest Expense | ||||||||
| Other Expense | 3.00 | (417.00) | (14.00) | 199.00 | (11.00) | 8.00 | (6.00) | 1,635 |
| Pretax Income | (16,700) | (14,412) | (10,215) | (10,254) | ||||
| Tax Provision | 0.00 | 500.00 | 0.00 | 0.00 | ||||
| Net Income (Loss) | (41,488) | (35,896) | (16,700) | (14,912) | (14,619) | (12,652) | (10,215) | (10,254) |
| Earnings Per Share (Basic) | (1.32) | (1.25) | (0.59) | (0.53) | (0.53) | (0.59) | (0.38) | (0.40) |
| Earnings Per Share (Diluted) | (1.32) | (1.25) | (0.59) | (0.53) | (0.53) | (0.59) | (0.38) | (0.40) |
| Weighted Average Shares Outstanding (Basic) | 31,353 | 28,813 | 28,541 | 28,079 | 27,526 | 21,281 | 27,172 | 25,609 |
| Weighted Average Shares Outstanding (Diluted) | 31,353 | 28,813 | 28,541 | 28,079 | 27,526 | 21,281 | 27,172 | 25,609 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LENZ
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is a stock listed on the Nasdaq Stock Market under the ticker symbol LENZ. It last traded at $3.27 (Oct 16, 2026, 4:00 PM ET), down 8.4% on the day. That gives LENZ Therapeutics a market capitalisation of $102.7M.
Over the past 52 weeks LENZ has traded between $3.21 and $42.98.
Revenue for the quarter ended Mar 31, 2026 was $1.9M; a net loss of $41.5M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.9M | -$41.5M | -2182.4% |
| Dec 31, 2025 | — | -$35.9M | — |
| Sep 30, 2025 | — | -$16.7M | — |
| Jun 30, 2025 | — | -$14.9M | — |
From LENZ Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…